SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-22-000244
Filing Date
2022-02-11
Accepted
2022-02-11 16:11:55
Documents
1
Group Members
DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT HIF, L.P.DEERFIELD MGMT IV, L.P.DEERFIELD MGMT, L.P.DEERFIELD PRIVATE DESIGN FUND IV, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e621289_sc13ga-mirum.htm SC 13G/A 156711
  Complete submission text file 0001193805-22-000244.txt   158294
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91075 | Film No.: 22620990
SIC: 2834 Pharmaceutical Preparations